查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018539

生物製藥輔料市場：2026年至2032年全球市場預測（依產品種類、原料、製劑種類及最終用戶分類）

Biopharmaceutical Excipients Market by Product, Source, Formulation Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，生物製藥輔料市場價值將達到 39.2 億美元，到 2026 年將成長至 42.5 億美元，到 2032 年將達到 77.2 億美元，複合年成長率為 10.17%。

主要市場統計數據
基準年 2025 39.2億美元
預計年份：2026年 42.5億美元
預測年份 2032 77.2億美元
複合年成長率 (%) 10.17%

生物製藥輔料的功能早已超越了傳統製劑中惰性載體的角色。如今，這些功能性成分已被公認為對藥物穩定性、生物利用度、生產過程和患者安全具有至關重要的影響。隨著市場向複雜生物製藥、個人化療法和複方製劑轉型，對輔料的需求呈指數級成長。決策者現在需要深入了解粘合劑、敷料、稀釋劑、崩壞、潤滑劑以及其他類別的輔料在整個生產、儲存和給藥過程中如何與活性成分相互作用。

本執行摘要概述了現代添加劑市場的基本要素，並提供了相關背景資訊。它重點介紹了重塑產業格局的關鍵促進因素，分析了影響全球供應鏈的監管和地緣政治趨勢，並闡明了按產品、原料、配方類型和最終用戶分類的關鍵細分維度。在此基礎上，本概要深入分析了區域趨勢、競爭格局，並為希望應對不確定性並掌握新機會的行業領導者提供了切實可行的建議。

探索技術進步和監管創新如何快速重塑生物製藥輔料的格局。

在製劑科學、數位技術進步以及日益成長的永續性需求的推動下，生物製藥輔料市場正經歷著一場變革浪潮。隨著生物製藥和基因療法的興起，製劑研發人員擴大採用新型聚合物基粘合劑和標靶釋放包衣，以滿足敏感分子的特定穩定性要求。同時，人工智慧 (AI) 和機器學習正在推動更具預測性的輔料篩檢，從而加快研發週期並降低實驗失敗率。

對 2025 年實施的美國新關稅對生物製藥輔料供應鏈和成本結構的影響進行全面評估。

美國將於2025年對進口添加劑原料加徵關稅，這為本已複雜的供應鏈帶來了新的挑戰。關鍵聚合物、多元醇和界面活性劑的關稅迫使製造商面臨更高的採購成本，影響了配方研發預算和商業化計畫。因此，尋找替代原料來源的步伐顯著加快，人們對國內產能的興趣也重新燃起。

對產品濃縮液配方和終端用戶細分進行詳細分析：為生物製藥輔料市場制定策略提供實用見解。

對市場區隔進行詳細檢驗，可提供有助於策略決策的關鍵洞察。依產品分類，產品範圍包括粘合劑，例如纖維素衍生物、羥丙基甲基纖維素、聚維酮和改質澱粉；包衣，包括緩釋包衣、腸溶包衣、薄膜包衣和糖基包衣；稀釋劑，例如磷酸鈣、乳糖和微晶纖維素；以及崩壞、潤滑劑、多元醇（例如甘露醇和山梨醇）、防腐劑、潤滑劑溶劑、增乳劑和山梨醇）、防腐劑、潤滑劑、化合物和懸浮劑、懸浮醇和山梨醇）、增乳劑、潤滑劑和山梨醇）、懸浮醇和山梨醇）。就原料來源而言，添加劑可分為天然來源和合成來源，二者在純度、永續性和監管要求方面均有差異。就製劑類型而言，市場涵蓋注射劑（可透過肌肉注射、靜脈注射和皮下注射）；口服製劑，包括膠囊、粉末和片劑；以及乳膏、凝膠、軟膏和洗劑等外用製劑，每種製劑都需要特定的功能特性。最後，最終用戶群體，包括生物製藥和製藥生產商、合約研發生產機構 (CDMO) 以及研究機構，凸顯了相關人員必須應對的需求和籌資策略的多樣性。

美洲、歐洲、中東和非洲以及亞太地區生物製藥輔料市場的區域趨勢和成長軌跡。

區域分析凸顯了各地區不同的成長動力，這主要受各自創新生態系統、法規環境和供應鏈能力的影響。在美洲，對先進藥物遞送平台的強勁需求推動了對新型粘合劑和包衣技術的投資。尤其是在美國，回流獎勵和關稅壓力共同促進了高純度添加劑的國內生產。放眼東方，歐洲、中東和非洲在嚴格的環境法規和促​​進跨境研發合作聯盟的舉措下，正穩步採用環保型和功能性添加劑。同時，亞太地區仍然是產能擴張的中心，中國、印度和東南亞的領先製造商利用成本競爭力和一體化供應通用服務於區域和全球市場。所有地區都高度重視供應穩定性、可追溯性和合規性，因為製造商力求降低地緣政治風險，並確保關鍵原料的持續供應。

競爭情報揭露了推動生物製藥輔料產業成長的主要企業的戰略舉措和創新路徑。

產業主要相關人員正加大力度，透過高性能添加劑的創新和策略夥伴關係來獲取競爭優勢。多家領先供應商已建立專注於聚合物科學和奈米技術的專門中心，致力於開發功能性塗層，以增強藥物的靶向釋放特性並提高患者的用藥依從性。同時，添加劑製造商與學術研究機構之間的合作正在加速新型配方平台的競爭前研究。

為產業領導者提供切實可行的策略建議，以加速創新、最佳化供應鏈並加強其在積層製造領域的市場地位。

為了在瞬息萬變的環境中取得成功，產業領導者應採取多管齊下的策略。首先，透過整合地緣政治穩定地區的二級供應商，實現採購多元化，可以降低關稅風險，防止供應中斷。同時，透過現有工廠和合約夥伴關係，投資於模組化和靈活的製造能力，能夠實現生產線的快速擴展和重新配置。

一套完善的調查方法，詳細介紹了資料收集三角測量和專家檢驗過程，為生物製藥輔料的分析提供了深入的見解。

本分析基於一套嚴謹的調查方法，結合了全面的數據摘要和專家檢驗。首先，作為一項輔助調查，我們深入查閱了監管指南、專利、白皮書和技術文獻，以梳理關鍵輔料的功能特性和合規要求。隨後，我們對領先的生物製藥公司的製劑科學家、採購經理和法規專家進行了訪談，以獲取有關新興挑戰和最佳實踐的第一手資料。

一份全面的結論，重點介紹生物製藥輔料市場的關鍵趨勢、挑戰和機遇，為決策提供資訊。

總而言之，生物製藥輔料市場正處於科學創新、監管變革和地緣政治格局轉變的交匯點。新一代粘合劑、包覆和遞送系統的巨大潛力，以及應對新關稅和供應鏈限制的緊迫性，目前正吸引廣泛關注。細分市場分析揭示了不同產品類型、來源、製劑類型和最終用戶之間存在的細微需求差異，而區域觀點凸顯了影響成長軌跡和投資重點的各種趨勢。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：生物製藥輔料市場：依產品類型分類

  • 粘合劑
    • 纖維素粘合劑
    • 羥丙基甲基纖維素
    • 聚乙烯吡咯烷酮
    • 澱粉和改質澱粉
  • 塗層劑
    • 緩釋塗層
    • 腸溶衣
    • 薄膜塗層
    • 密封塗層
    • 糖霜
  • 沖淡
    • 磷酸鈣
    • 乳糖
    • 微晶纖維素
  • 崩壞
  • 潤滑劑
  • 多元醇
    • 甘露醇
    • 山梨醇
  • 防腐劑
  • 增溶劑/界面活性劑/乳化劑
    • 酯
    • 聚山梨醇酯
    • 三酸甘油酯
  • 懸浮劑和增稠劑

第9章：生物製藥輔料市場：依原料分類

  • 天然輔料
  • 合成輔料

第10章：生物製藥輔料市場：依製劑類型分類

  • 注射藥物
    • 肌肉內部
    • 靜脈
    • 皮下
  • 口服製劑
    • 膠囊
    • 粉末
    • 藥片
  • 外用製劑
    • 奶油
    • 凝膠/軟膏
    • 洗劑

第11章：生物製藥輔料市場：以最終用戶分類

  • 生物製藥和製藥公司
  • 契約製造
  • 研究機構

第12章：生物製藥輔料市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：生物製藥輔料市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：生物製藥輔料市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國：生物製藥輔料市場

第16章 中國：生物製藥輔料市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ABITEC Corporation
  • Actylis
  • Asahi Kasei Corporation
  • Ashland Inc.
  • Avantor, Inc.
  • BASF SE
  • Clariant International Ltd.
  • Colorcon Ltd.
  • Croda International PLC
  • DFE Pharma GmbH & Co KG
  • Eastman Chemical Company
  • Evonik Industries AG
  • Fuji Chemical Industries Co., Ltd.
  • IMCD NV
  • Innophos Holdings, Inc.
  • International Flavors & Fragrances Inc.
  • JRS PHARMA GmbH+Co. KG
  • Kerry Group PLC
  • Meggle Group GmbH
  • Merck KGaA
  • Mitsubishi Chemical Group Corporation
  • NOF Corporation
  • Novo Nordisk A/S
  • Pfanstiehl, Inc.
  • Roquette Freres SA
  • Shin-Etsu Chemical Co., Ltd.
  • Sigachi Industries Limited
  • Spectrum Laboratory Products, Inc.
  • SPI Pharma, Inc. By Associated British Foods
  • The Archer-Daniels-Midland Company
  • The Dow Chemical Company
  • The Lubrizol Corporation
  • Wacker Chemie AG
Product Code: MRR-A339DAEFAD78

The Biopharmaceutical Excipients Market was valued at USD 3.92 billion in 2025 and is projected to grow to USD 4.25 billion in 2026, with a CAGR of 10.17%, reaching USD 7.72 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.92 billion
Estimated Year [2026] USD 4.25 billion
Forecast Year [2032] USD 7.72 billion
CAGR (%) 10.17%

Biopharmaceutical excipients have evolved far beyond their traditional role as inert carriers in drug formulation. Today, these functional ingredients are recognized for their critical influence on drug stability, bioavailability, manufacturability, and patient safety. As the landscape shifts toward complex biologics, personalized therapies, and combination products, the demands placed on excipients have grown exponentially. Decision makers now require a nuanced understanding of how binders, coatings, diluents, disintegrants, lubricants, and other categories interact with active pharmaceutical ingredients during production, storage, and delivery.

In this executive summary, we set the stage by outlining the foundational elements that define the modern excipients market. We introduce the primary drivers reshaping the industry, survey the regulatory and geopolitical currents that affect global supply chains, and delineate key segmentation dimensions by product, source, formulation type, and end user. With this contextual framework in place, we deliver insights into regional dynamics, competitive positioning, and actionable recommendations for industry leaders seeking to navigate uncertainty and capitalize on emerging prospects.

Exploring Rapid Transformations Reshaping the Biopharmaceutical Excipients Landscape Through Technological Advances and Regulatory Innovation

The biopharmaceutical excipients landscape is currently undergoing a wave of transformation fueled by advances in formulation science, digital technologies, and sustainability imperatives. Driven by the rise of biologics and gene therapies, formulators are increasingly incorporating novel polymeric binders and targeted release coatings to address the unique stability requirements of sensitive molecules. At the same time, artificial intelligence and machine learning are enabling more predictive excipient screening, accelerating development timelines and reducing experimental failure rates.

Furthermore, regulatory agencies around the world have tightened guidelines related to excipient characterization and safety, prompting manufacturers to adopt more rigorous quality by design principles. Concurrently, the industry is embracing green chemistry practices, with sourcing strategies focused on renewable natural excipients and ecofriendly manufacturing processes. As a result, the competitive environment is shifting toward suppliers that can demonstrate robust traceability, low aqueous content, and reduced environmental footprints, thereby creating a new benchmark for innovation and compliance.

Evaluating the Comprehensive Impact of Newly Implemented United States Tariffs in 2025 on Biopharmaceutical Excipients Supply Chain and Cost Structures

The implementation of United States tariffs in 2025 on a range of imported excipient raw materials has introduced fresh complexities into an already intricate supply chain. With levies impacting key polymers, polyols, and surfactants, manufacturers are grappling with higher procurement costs that ripple through formulation budgets and commercialization plans. As a direct consequence, there has been a marked acceleration in the search for alternative ingredient sources and a renewed interest in domestic production capabilities.

Moreover, the tariff-induced cost pressures have underscored the need for agility in supplier relationships, prompting companies to strengthen partnerships with upstream producers in regions less affected by these duties. In parallel, formulation teams are reexamining excipient specifications to identify opportunities for benchmarking lower-cost analogs without compromising performance. Collectively, these actions are reshaping the operational playbook for excipient supply chain management and demanding agile responses from stakeholders across the value chain.

In-Depth Analysis of Product Source Formulation and End User Segmentation Delivering Actionable Insights for Biopharmaceutical Excipients Market Strategy

A granular examination of market segmentation reveals pivotal insights that inform strategic decision making. When categorizing by product, the landscape spans binders such as cellulosic derivatives, hydroxypropyl methylcellulose, povidone, and modified starches; coatings ranging from controlled release and enteric to film and sugar-based variants; diluents including calcium phosphates, lactose, and microcrystalline cellulose; as well as disintegrants, lubricants, polyols like mannitol and sorbitol, preservatives, solubilizers and surfactants forming emulsifier systems, and suspending agents. Considering source, excipients derive from either natural origins or synthetic processes, each offering distinct purity, sustainability profiles, and regulatory considerations. In terms of formulation type, the market covers injectables with intramuscular, intravenous, and subcutaneous routes; oral delivery systems encompassing capsules, powders, and tablets; and topical forms such as creams, gels, ointments, and lotions, each demanding specific functional attributes. Finally, the end user spectrum, comprising biopharmaceutical and pharmaceutical manufacturers, contract development and manufacturing organizations, and research institutions, underscores the diversity of requirements and procurement strategies that stakeholders must navigate.

Regional Performance Dynamics and Growth Trajectories Across the Americas Europe Middle East Africa and Asia Pacific Biopharmaceutical Excipients Markets

Regional analysis underscores differentiated growth dynamics driven by local innovation ecosystems, regulatory environments, and supply chain capabilities. In the Americas, strong demand for advanced drug delivery platforms is catalyzing investment in novel binder and coating technologies, particularly in the United States where reshoring incentives and tariff pressures converge to support domestic manufacturing of high-purity excipients. Moving eastward, Europe, Middle East and Africa exhibit steady uptake of green and functional excipients, spurred by stringent environmental regulations and collaborative consortiums that foster cross-border R&D initiatives. Meanwhile, Asia-Pacific remains a hotbed of capacity expansion, with major producers in China, India, and Southeast Asia leveraging cost competitiveness and integrated supply chains to serve both regional and global markets. Consistent across all regions is an emphasis on supply security, traceability, and regulatory alignment, as manufacturers seek to mitigate geopolitical risks and maintain uninterrupted access to critical materials.

Competitive Intelligence Revealing Key Industry Players Strategic Initiatives and Innovation Pathways Driving Growth in Biopharmaceutical Excipients Sector

Key industry participants are intensifying efforts to secure competitive advantage through innovation in high-performance excipients and strategic partnerships. Several leading suppliers have established dedicated centers of excellence for polymer science and nanotechnology, enabling the development of functional coatings that enhance targeted release profiles and improve patient compliance. Simultaneously, collaborative alliances between excipient producers and academic research institutions are accelerating pre-competitive studies on novel formulation platforms.

In addition, companies are leveraging digital platforms to offer lifecycle management services that integrate real-time quality monitoring, predictive maintenance of production lines, and digital exchange of material data with customers. Partnerships with specialty chemical manufacturers and raw material providers are also on the rise, as stakeholders aim to ensure uninterrupted feedstock availability in light of recent tariff-driven supply chain disruptions. Taken together, these strategic initiatives underscore the industry's commitment to differentiation through technology, service excellence, and resilient sourcing strategies.

Actionable Strategic Recommendations Enabling Industry Leaders to Accelerate Innovation Optimize Supply Chains and Enhance Market Position in Excipients Development

To thrive in this dynamic environment, industry leaders should adopt a multi-pronged approach. First, diversifying sourcing by integrating second-tier suppliers from geopolitically stable regions can mitigate tariff risk and prevent disruptions. At the same time, investing in modular, flexible manufacturing capabilities-both in existing plants and through contract partnerships-will allow rapid scale-up or reconfiguration of production lines.

Furthermore, directing R&D budgets toward sustainable excipient platforms that deliver comparable performance with a reduced ecological footprint will address both regulatory expectations and end-user demand. Collaborative engagement with regulatory bodies to establish clear quality standards for novel materials can streamline approval timelines. Finally, harnessing digital tools for predictive analytics and material informatics will improve formulation success rates and accelerate time to market, ultimately enhancing competitiveness.

Robust Research Methodology Detailing Data Collection Triangulation and Expert Validation Processes Underpinning Insights in Biopharmaceutical Excipients Analysis

This analysis is built upon a robust methodology combining comprehensive data aggregation and expert validation. Initially, secondary research involved a thorough review of regulatory guidelines, patents, white papers, and technical publications to map the functional attributes and compliance requirements of key excipients. Following this, primary interviews were conducted with formulation scientists, procurement executives, and regulatory specialists from leading biopharmaceutical organizations to capture firsthand insights into emerging challenges and best practices.

To ensure accuracy and objectivity, data points were triangulated across multiple sources, including proprietary supplier databases and academic research repositories. Quantitative inputs were corroborated through material property testing reports, while qualitative trends were cross-verified with industry experts during iterative review cycles. This structured approach guarantees that the findings presented herein reflect the most current, reliable, and actionable intelligence available to decision makers.

Consolidated Conclusions Emphasizing Critical Trends Challenges and Opportunities to Inform Decision Making in the Biopharmaceutical Excipients Landscape

In summary, the biopharmaceutical excipients market stands at the intersection of scientific innovation, regulatory evolution, and geopolitical shifts. The transformative potential of next-generation binders, coatings, and delivery systems is now matched by the urgency to navigate newly imposed tariffs and supply chain constraints. Segmentation analysis reveals the nuanced requirements across product categories, sources, formulation types, and end users, while regional perspectives highlight the divergent dynamics that influence growth trajectories and investment priorities.

Competitive landscapes are being redefined by players that excel in functional innovation, sustainable practices, and supply chain resilience. Moving forward, organizations that embrace diversification, digitalization, and collaborative regulation will be best positioned to harness emerging opportunities. Ultimately, success in this sector will depend on the ability to integrate cutting-edge science with strategic foresight and operational agility.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biopharmaceutical Excipients Market, by Product

  • 8.1. Binders
    • 8.1.1. Cellulosic Binders
    • 8.1.2. Hydroxypropyl Methylcellulose
    • 8.1.3. Polyvinylpyrrolidone
    • 8.1.4. Starch & Modified Starches
  • 8.2. Coatings
    • 8.2.1. Controlled Release Coatings
    • 8.2.2. Enteric Coatings
    • 8.2.3. Film Coatings
    • 8.2.4. Seal Coatings
    • 8.2.5. Sugar Coatings
  • 8.3. Diluents
    • 8.3.1. Calcium Phosphates
    • 8.3.2. Lactose
    • 8.3.3. Microcrystalline Cellulose
  • 8.4. Disintegrants
  • 8.5. Lubricants & Glidants
  • 8.6. Polyols
    • 8.6.1. Mannitol
    • 8.6.2. Sorbitol
  • 8.7. Preservatives
  • 8.8. Solubilizers & Surfactants/Emulsifiers
    • 8.8.1. Esters
    • 8.8.2. Polysorbates
    • 8.8.3. Triglycerides
  • 8.9. Suspending & Viscosity Agents

9. Biopharmaceutical Excipients Market, by Source

  • 9.1. Natural Excipients
  • 9.2. Synthetic Excipients

10. Biopharmaceutical Excipients Market, by Formulation Type

  • 10.1. Injectable Formulations
    • 10.1.1. Intramuscular
    • 10.1.2. Intravenous
    • 10.1.3. Subcutaneous
  • 10.2. Oral Formulations
    • 10.2.1. Capsules
    • 10.2.2. Powders
    • 10.2.3. Tablets
  • 10.3. Topical Formulations
    • 10.3.1. Creams
    • 10.3.2. Gels & Ointments
    • 10.3.3. Lotions

11. Biopharmaceutical Excipients Market, by End User

  • 11.1. Biopharmaceutical & Pharmaceutical Companies
  • 11.2. Contract Manufacturers
  • 11.3. Research Institutes

12. Biopharmaceutical Excipients Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Biopharmaceutical Excipients Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Biopharmaceutical Excipients Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Biopharmaceutical Excipients Market

16. China Biopharmaceutical Excipients Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. ABITEC Corporation
  • 17.6. Actylis
  • 17.7. Asahi Kasei Corporation
  • 17.8. Ashland Inc.
  • 17.9. Avantor, Inc.
  • 17.10. BASF SE
  • 17.11. Clariant International Ltd.
  • 17.12. Colorcon Ltd.
  • 17.13. Croda International PLC
  • 17.14. DFE Pharma GmbH & Co KG
  • 17.15. Eastman Chemical Company
  • 17.16. Evonik Industries AG
  • 17.17. Fuji Chemical Industries Co., Ltd.
  • 17.18. IMCD N.V.
  • 17.19. Innophos Holdings, Inc.
  • 17.20. International Flavors & Fragrances Inc.
  • 17.21. JRS PHARMA GmbH + Co. KG
  • 17.22. Kerry Group PLC
  • 17.23. Meggle Group GmbH
  • 17.24. Merck KGaA
  • 17.25. Mitsubishi Chemical Group Corporation
  • 17.26. NOF Corporation
  • 17.27. Novo Nordisk A/S
  • 17.28. Pfanstiehl, Inc.
  • 17.29. Roquette Freres S.A.
  • 17.30. Shin-Etsu Chemical Co., Ltd.
  • 17.31. Sigachi Industries Limited
  • 17.32. Spectrum Laboratory Products, Inc.
  • 17.33. SPI Pharma, Inc. By Associated British Foods
  • 17.34. The Archer-Daniels-Midland Company
  • 17.35. The Dow Chemical Company
  • 17.36. The Lubrizol Corporation
  • 17.37. Wacker Chemie AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. GCC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 263. GCC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 264. GCC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2032 (USD MILLION)
  • TABLE 265. GCC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
  • TABLE 266. GCC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2032 (USD MILLION)
  • TABLE 267. GCC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2032 (USD MILLION)
  • TABLE 268. GCC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2032 (USD MILLION)
  • TABLE 269. GCC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 270. GCC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. GCC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 272. GCC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 273. GCC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 274. GCC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 201